These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8556409)

  • 1. [Withdrawal in opiate addicts in an internal medicine hospital unit].
    Crémer GA; Boissonnas A
    Bull Acad Natl Med; 1995 Oct; 179(7):1335-51; discussion 1351-4. PubMed ID: 8556409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acupuncture as a part of a program of detoxification and weaning from opiates: 25 cases].
    Lorini G; Fazio L; Cocchi R; Fusari A; Roccia L
    Minerva Med; 1979 Dec; 70(56):3831-6. PubMed ID: 537697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts].
    Gorceix A; Dugarin J; Pommier F
    Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
    Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up control after long-term withdrawal therapy in heroin and multiple drug addicts].
    Seiler D; Schuler S
    Dtsch Med Wochenschr; 1983 Jun; 108(22):858-62. PubMed ID: 6851878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine and naloxone interactions in opiate-dependent volunteers.
    Mendelson J; Jones RT; Fernandez I; Welm S; Melby AK; Baggott MJ
    Clin Pharmacol Ther; 1996 Jul; 60(1):105-14. PubMed ID: 8689806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of qigong therapy in the detoxification of heroin addicts.
    Li M; Chen K; Mo Z
    Altern Ther Health Med; 2002; 8(1):50-4, 56-9. PubMed ID: 11795622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.